Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: From molecular modeling to in vivo evaluation

This publication has 35 references indexed in Scilit:

• Peptide-based radiopharmaceuticals and cytotoxic conjugates: Potential tools against cancer
  Cancer Treatment Reviews, 2008
• Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours
  Endocrine-Related Cancer, 2006
• Cholecystokinin‐B (CCK‐B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK‐B receptor expressing malignancies
  Peptide Science, 2002
• Effect of Gastrin and Anti-Gastrin Antibodies on Proliferation of Hepatocyte Cell Lines
  Digestive Diseases and Sciences, 2001
• Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides
  Current Medicinal Chemistry, 2000
• Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma
  Journal of Hepatology, 1999
• Coexpression of gastrin and gastrin receptors (CCK-B and ΔCCK-B) in gastrointestinal tumour cell lines
  Gut, 1998
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin
  British Journal of Cancer, 1992
• Binding specificity of the mouse cerebral cortex receptor for small cholecystokinin peptides
  Regulatory Peptides, 1984